Try our mobile app

Published: 2023-04-26 20:21:03 ET
<<<  go to BAK company page
6-K 1 bak20230426_6k1.htm FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of April, 2023

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

 

DETAILED FINAL VOTING MAP

ANNUAL AND EXTRAORDINARY GENERAL MEETING

HELD ON APRIL 26, 2023

 

São Paulo, April 26, 2023 – Braskem S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) (“Company”), in compliance with CVM Resolution No. 81/22, as amended, hereby disclose to its shareholders and the market the detailed final voting map which consolidates the voting instructions of both shareholders which voted through remote voting (boletim de voto a distância) and those during the Meeting, as computed at the Annual and Extraordinary General Meeting of the Company held on April 13, 2021, including the first five digits of the shareholders’ individual or corporate taxpayer identification number (CPF or CNPJ, respectively), their vote on each item, and information about their shareholding position, as EXHIBIT I.

Further information can be obtained from Braskem’s Investor Relations Department by phone: +55 (11) 3576-9531 or by e-mail: braskem-ri@braskem.com.br

 

 

 

 
 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

EXHIBIT I

DETAILED FINAL VOTING MAP

ANNUAL AND EXTRAORDINARY GENERAL MEETING

HELD ON APRIL 26, 2023

 

Resolutions
Annual General Meeting
1 Examine, discuss, and vote on Company’s Financial Statement containing the Notes to Financial Statements, along with the Report and Opinion of the Independent Auditors, the Opinion of the Fiscal Council and the report of the Compliance and Statutory Audit Committee, for the fiscal year ended December 31, 2022.
2 Examine, discuss, and vote the Management Proposal and respective Management Account for the fiscal year ended December 31, 2022.
3 Do you want to request the adoption of the separate election by minority Shareholders of common shares of a member to the Fiscal Council, under the terms of the article 161, paragraph 4, “a”, of the Brazilian Corporation Law?
4 Nomination of candidates to the fiscal council by shareholders with non-voting preferred shares or restricted voting rights - WILFREDO JOÃO VICENTE GOMES (Effective) / IÊDA APARECIDA DE MOURA CAGNI (Alternate)
5 Nomination of all the names that compose the slate - CHAPA ÚNICA INDICADA PELAS ACIONISTAS NOVONOR S.A. – EM RECUPERAÇÃO JUDICIAL E NSP INVESTIMENTOS S.A. – EM RECUPERAÇÃO JUDICIAL E PELA ACIONISTA PETRÓLEO BRASILEIRO S.A. – PETROBRAS
6 If one of the candidates of the slate leaves it, to accommodate the separate election referred to in articles 161, paragraph 4, and 240 of Law 6404, of 1976, can the votes corresponding to your shares continue to be conferred to the same slate?
7 Resolve the annual and global Management and Fiscal Council compensation for the fiscal year to be ended on December 31, 2023.
Extraordinary General Meeting
1 Ratification, pursuant to article 23 of the Companys Bylaws, of the appointment by the Board of Directors of one (1) effective member of the Companys Board of Directors, for the remainder of the term of office in progress, until the Companys Annual General Meeting which will resolve on the financial statements for the fiscal year to end on December 31, 2023.
2 Re-ratification of the amount declared as additional dividends at the Companys Annual and Extraordinary Shareholders Meeting held on April 19, 2022, with the consequent adjustment in the amount of retained earnings by the Company, for the year 2021, based on the Company’s capital budget for the year 2022.

 

 
 

 

 

Description of the Resolution CNPJ/CPF
(first 5 digits)
Resolution Vote Numbers of Shares
(ON)¹ (PN)²
Annual General Meeting
1 33000 APROVAL 212,426,952 -
54579 APROVAL 4,105,662 -
76423 APROVAL 6 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 ABSTENTION 4,600,000 -
2 33000 APROVAL 212,426,952 -
54579 APROVAL 4,105,662 -
76423 APROVAL 6 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 ABSTENTION 4,600,000 -
3 54579 ABSTENTION 4,105,662 -
76423 APROVAL 6 -
89351 ABSTENTION 4,600,000 -
 
 

 

 

 

4 55237 APROVAL - 8,401,542
55237 REJECTION - 166,268
55237 ABSTENTION - 560,816
89351 APROVAL - 21,221,246
24065 APROVAL - 3,900
21407 APROVAL - 236,724
11184 APROVAL - 1,935
13416 APROVAL - 48,851
12984 APROVAL - 6,833
70965 APROVAL - 6,194
20147 APROVAL - 43,952
76866 APROVAL - 1,834
18138 APROVAL - 18,976
10263 APROVAL - 60,172
28872 APROVAL - 24,629
60699 APROVAL - 20,189
37347 APROVAL - 87,294
19388 APROVAL - 47,096
33700 APROVAL - 97,114
14416 APROVAL - 98,381
42332 APROVAL - 29,775
47518 APROVAL - 21,356
35726 APROVAL - 23,100
39332 APROVAL - 97
54791 APROVAL - 342,800
54797 APROVAL - 297,013
58387 APROVAL - 24,477
58392 APROVAL - 3,600
58394 APROVAL - 161,955
58394 APROVAL - 2,476,500
58396 APROVAL - 18,160,925
58397 APROVAL - 80,000
58400 APROVAL - 28,900
58400 APROVAL - 82,539
59868 APROVAL - 27,800
59873 APROVAL - 1,547
62390 APROVAL - 8,600
71409 APROVAL - 2,524
71409 APROVAL - 1,700
72087 APROVAL - 14,100
72473 APROVAL - 35,900
74963 APROVAL - 64,082
75166 APROVAL - 8,464
87318 APROVAL - 3,500
87889 APROVAL - 107,700
88575 APROVAL - 351,500
90019 APROVAL - 92,900
90633 APROVAL - 350,109
90735 APROVAL - 14,180
91457 APROVAL - 504,348
94700 APROVAL - 7,700
95596 APROVAL - 96,180
10205 APROVAL - 351
10916 APROVAL - 234,173
11100 APROVAL - 264,676
11311 APROVAL - 114,081
11324 APROVAL - 7,400
11514 APROVAL - 462,663
11729 APROVAL - 16,400
12094 APROVAL - 39,200
12120 APROVAL - 48,400
13296 APROVAL - 7,727
14204 APROVAL - 32,378
14258 APROVAL - 41
14494 APROVAL - 8,192
14541 APROVAL - 104,200
14588 APROVAL - 34,100
16878 APROVAL - 5,500
16990 APROVAL - 180,500
17212 APROVAL - 107,600
17372 APROVAL - 58,500
17718 APROVAL - 340,596
18103 APROVAL - -
18830 APROVAL - 6,900
19530 APROVAL - 5,851
20813 APROVAL - 271,140
20849 APROVAL - 600
21542 APROVAL - 2,000
22403 APROVAL - 344,095
22420 APROVAL - 147,240
23442 APROVAL - 13,662
23847 APROVAL - 9,900
23847 APROVAL - 67,800
24158 APROVAL - 15,996
24569 APROVAL - 1,079
24728 APROVAL - 1,000
25271 APROVAL - 14,402
25271 APROVAL - 32,070
26160 APROVAL - 4,100
26301 APROVAL - 62,400
26311 APROVAL - 4,100
26784 APROVAL - 3,600
27366 APROVAL - 73,668
27545 APROVAL - 14,000
27624 APROVAL - 5,881
27703 APROVAL - -
27778 APROVAL - 26,690
27866 APROVAL - 664
27866 APROVAL - 4,648
28360 APROVAL - 692
28394 APROVAL - 14,300
28979 APROVAL - 200
28990 APROVAL - 139,500
29322 APROVAL - 1,887,969
30066 APROVAL - -
30254 APROVAL - 14,994
30463 APROVAL - 82,600
30918 APROVAL - 81,307
31050 APROVAL - -
31577 APROVAL - 16,800
32106 APROVAL - 2,750
32329 APROVAL - 109,836
33580 APROVAL - 19,100
33968 APROVAL - 18,810
34662 APROVAL - 116,200
34825 APROVAL - 765
35693 APROVAL - 1,133,500
36540 APROVAL - 527
37806 APROVAL - 1,513
38756 APROVAL - 14,700
41063 APROVAL - 30,000
41222 APROVAL - 42,800
41272 APROVAL - 6,500
41286 APROVAL - 25,500
41941 APROVAL - 1,113
42887 APROVAL - 1,000
43068 APROVAL - 305,380
44602 APROVAL - 694
45919 APROVAL - 14,081
46964 APROVAL - 51,300
46981 APROVAL - 1,006
48123 APROVAL - 4,070
48429 APROVAL - 2,100
97539 APROVAL - 21,100
97539 APROVAL - 28,270
97539 APROVAL - -
97540 APROVAL - 26,171
97540 APROVAL - 2,134,883
5 33000 APROVAL 212,426,952 -
54579 APROVAL 4,105,662 -
76423 REJECTION 6 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 ABSTENTION 4,600,000 -
6 54579 ABSTENTION 4,105,662 -
89351 ABSTENTION 4,600,000 -
 
 

 

7 33000 APROVAL 212,426,952 -
54579 APROVAL 4,105,662 -
76423 REJECTION 6 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 ABSTENTION 4,600,000 -
Extraordinary General Meeting
1 33000 APROVAL 212,426,952 -
54579 APROVAL 4,105,662 -
76423 APROVAL 6 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 REJECTION 4,600,000 -
2 33000 APROVAL 212,426,952 -
54579 APROVAL 4,105,662 -
76423 APROVAL 6 -
22606 APROVAL 226,334,622 -
51447 APROVAL 1 -
89351 REJECTION 4,600,000 -

 

(1) ON shares are common shares issued by the Company. It does not take into consideration Treasury Stock.

(2) PN Shares are preferred shares of class A and B issued by the Company, which have the right to vote only and exclusively for separate election of the Fiscal Council, under the terms of article 161, paragraph 4, item "a", of Corporation Law. It does not take into consideration Treasury Stock.

 

 

 

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 26, 2023

  BRASKEM S.A.
       
       
  By:      /s/     Pedro van Langendonck Teixeira de Freitas
     
    Name: Pedro van Langendonck Teixeira de Freitas
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.